You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chinese Participants

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers Trial (BMS-986278, Placebo)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Mar 28, 2023

COVID-19 Respiratory Infection Trial in Changchun (GST-HG171/ritonavir, ritonavir)

Active, not recruiting
  • COVID-19 Respiratory Infection
  • Changchun, Jilin, China
    The first hospital of Jilin University
Oct 10, 2023

Overweight, Obesity Trial (LY3502970, Placebo)

Not yet recruiting
  • Overweight
  • Obesity
  • (no location specified)
Aug 29, 2023

Healthy Trial in Beijing (JNJ-63733657)

Completed
  • Healthy
  • Beijing, China
    Peking University Third Hospital
Jan 3, 2023

Healthy Trial in Shanghai (Recifercept)

Not yet recruiting
  • Healthy
  • Shanghai, Shanghai, China
  • +1 more
Jan 4, 2023

Healthy Trial in Fukuoka (JNJ-77242113, Placebo)

Completed
  • Healthy
  • Fukuoka, Japan
    Souseikai Hakata Clinic
Nov 22, 2022

Healthy Volunteers Trial (ABBV-903, Placebo for ABBV-903)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Aug 21, 2023

Overweight, Obesity Trial in Cheng Du, Beijing (LY3437943, Placebo)

Recruiting
  • Overweight
  • Obesity
  • Cheng Du, Sichuan, China
  • +1 more
Dec 8, 2022

Advanced Solid Tumors Trial in Beijing (BMS-986213)

Recruiting
  • Advanced Solid Tumors
  • Beijing, Beijing, China
  • +1 more
Nov 21, 2022

Plaque Psoriasis Trial (apremilast, Placebo)

Not yet recruiting
  • Plaque Psoriasis
  • (no location specified)
Nov 3, 2023

Healthy Volunteers Trial in Grayslake (Lutikizumab Dose A, Lutikizumab Dose B)

Recruiting
  • Healthy Volunteers
  • Lutikizumab Dose A
  • Lutikizumab Dose B
  • Grayslake, Illinois
    Acpru /Id# 259029
Oct 4, 2023

Healthy Trial in Guangzhou (JNJ-77474462)

Not yet recruiting
  • Healthy
  • Guangzhou, China
    Nanfang Hospital of Southern Medical Hospital
Aug 2, 2022

Healthy Study Participants Trial (UCB0599, Esomeprazole, Placebo)

Not yet recruiting
  • Healthy Study Participants
  • (no location specified)
Apr 25, 2023

Asthma Trial (GSK3511294)

Active, not recruiting
  • Asthma
  • GSK3511294
  • Hangzhou, Zhejiang, China
    GSK Investigational Site
Oct 21, 2022

Advanced Solid Tumors Trial in Shanghai (Relatlimab, Nivolumab)

Not yet recruiting
  • Advanced Solid Tumors
  • Relatlimab
  • Nivolumab
  • Shanghai, Shanghai, China
    Local Institution
Aug 10, 2022

Healthy Participants Trial in Shanghai (PF-07321332/ritonavir)

Completed
  • Healthy Participants
  • Shanghai, Shanghai, China
    Huashan Hospital,Fudan University
Jun 28, 2022

Migraine Trial (Rimegepant, Placebo)

Not yet recruiting
  • Migraine
  • (no location specified)
Mar 30, 2023

Chronic Migraine Trial in Beijing, Taiyuan, Hangzhou (Atogepant)

Completed
  • Chronic Migraine
  • Beijing, Beijing, China
  • +2 more
Dec 21, 2022

Healthy Trial in Beijing (First Test Concor (Fasted), First Reference Concor (Fasted), First Test Concor (Fed))

Recruiting
  • Healthy
  • First Test Concor (Fasted)
  • +3 more
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University-Drug Cli
Jun 26, 2023

Oral Upadacitinib Tablets to Assess Adverse Events and Change in

Not yet recruiting
  • Atopic Dermatitis (AD)
    • (no location specified)
    Jul 17, 2023

    DLBCL Trial (Polatuzumab Vedotin)

    Not yet recruiting
    • Diffuse Large B-Cell Lymphoma
    • Polatuzumab Vedotin
    • (no location specified)
    Jul 12, 2023

    Solid Tumors Trial (BGB-B167, Tislelizumab)

    Not yet recruiting
    • Solid Tumors
    • (no location specified)
    Dec 1, 2022

    Trastuzumab Emtansine as Therapy in Chinese HER2 Positive

    Not yet recruiting
    • Breast Cancer
    • Trastuzumab emtansine
    • (no location specified)
    Jul 13, 2023

    Solid Tumors Trial in Shanghai City (Ipatasertib)

    Active, not recruiting
    • Solid Tumors
    • Shanghai City, China
      Fudan University Shanghai Cancer Center
    Jan 8, 2023

    Healthy Participant Trial in Changchun (GST-HG171/Ritonavir, Itraconazole)

    Completed
    • Healthy Participant
    • Changchun, Jilin, China
      The first hospital of Jilin University
    Oct 11, 2023